Tag: REGN stock

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) concluded the trading at $700.33 on on Friday, February 21 with a rise of 0.62% from its closing price on previous day. Company’s P/E ratio for the trailing 12 months is 18.29. Considering stock’s 52-week price range provides that REGN hit

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) price on Friday, February 07, fall -1.67% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $710.00. A look at the stock’s price movement, the close in the last trading session was $722.07, moving